The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: A review
Open accessAbstract
Worsening of diabetic retinopathy (DR) is associated with the initiation of effective treatment of glycaemia in some patients with diabetes. It has been associated with risk factors such as poor blood‐glucose control and hypertension, and it manifests prior to the long‐term benefits of optimizing glycaemic control. The majority of evidence supports an association of large and rapid reductions in blood‐glucose levels with early worsening of DR. Despite a general awareness of early worsening within the diabetes community, mechanisms to explain the phenomenon remain speculative. We provide an overview of early worsening of DR and its pathophysiology based on current data. We describe the phenomenon in various settings, including in patients receiving insulin‐ or non‐insulin‐based treatments, in those undergoing bariatric surgery, and in pregnant women. We discuss various mechanisms and theories that have been suggested to explain this paradoxical phenomenon, and we summarize the implications of these in clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
Self-citationStearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,094
(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985
Wilkinson, C. P., Ferris, F. L., Klein, R. E., Lee, P. P., Agardh, C. D., Davis, M., Dills, D., Kampik, A., Pararajasegaram, R., & Verdaguer, J. T. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00475-5 · Cited by 3,743
Basal insulin and cardiovascular and other outcomes in dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203858 · Cited by 1,636
Effects of medical therapies on retinopathy progression in type 2 diabetes
The ACCORD Study Group and ACCORD Eye Study Group (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001288 · Cited by 1,311 · cited 3×
“The evidence for early worsening in patients with type 2 diabetes is limited because many large randomized controlled trials, for example the ADVANCE and ACCORD trials, evaluated only the effect of intensive vs conventional therapy on DR progression, assessed as retinal change at trial end rather than as an early outc…”
BackgroundWong, T. Y., Cheung, C. M. G., Larsen, M., Sharma, S., & Simó, R. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.12 · Cited by 1,094
Diabetic Retinopathy: A Position Statement by the American Diabetes Association
Solomon, S. D., Chew, E., Duh, E. J., Sobrin, L., Sun, J. K., VanderBeek, B. L., Wykoff, C. C., & Gardner, T. W. (2017) · Diabetes Care · doi:10.2337/dc16-2641 · Cited by 940
Pratley, R. E., Aroda, V. R., Lingvay, I., Lüdemann, J., Andreassen, C., Navarria, A., & Viljoen, A. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30024-x · Cited by 790
Wolff, L. F., Smith, Q. T., Snyder, W. K., Bedrick, J. A., Liljemark, W. F., Aeppli, D. A., & Bandt, C. L. (1988) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.1988.tb01003.x · Cited by 577
Zoungas, S., Arima, H., Gerstein, H. C., Holman, R. R., Woodward, M., Reaven, P., Hayward, R. A., Craven, T., Coleman, R. L., & Chalmers, J. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30104-3 · Cited by 529
Early Worsening of Diabetic Retinopathy in the Diabetes Control and Complications Trial
(1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.7.874 · Cited by 509
Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives
Simó, R., & Hernández, C. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.09.005 · Cited by 490
Basal Insulin Therapy in Type 2 Diabetes
Rosenstock, J., Schwartz, S. L., Clark, C. M., Park, G. D., Donley, D. W., & Edwards, M. B. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.631 · Cited by 478
The Kroc Collaborative Study Group* (1984) · New England Journal of Medicine · doi:10.1056/nejm198408093110604 · Cited by 468
Metabolic Control and Progression of Retinopathy: The Diabetes in Early Pregnancy Study
Chew, E. Y., Mills, J. L., Metzger, B. E., Remaley, N. A., Jovanovic-Peterson, L., Knopp, R. H., Conley, M., Rand, L., Simpson, J. L., Holmes, L. B., et al. (1995) · Diabetes Care · doi:10.2337/diacare.18.5.631 · Cited by 402
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.11.1631 · Cited by 395
EFFECT OF 1 YEAR OF NEAR-NORMAL BLOOD GLUCOSE LEVELS ON RETINOPATHY IN INSULIN-DEPENDENT DIABETICS
Lauritzen, T., Larsen, H.-W., Frost-Larsen, K., Deckert, T., & The Steno Study Group (1983) · The Lancet · doi:10.1016/s0140-6736(83)92585-0 · Cited by 373
The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group (2015) · Diabetes · doi:10.2337/db14-0930 · Cited by 333
Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy
Vilsbøll, T., Bain, S. C., Leiter, L. A., Lingvay, I., Matthews, D., Simó, R., Helmark, I. C., Wijayasinghe, N., & Larsen, M. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13172 · Cited by 318
Self-citation10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s010 · Cited by 302
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
Fullerton, B., Jeitler, K., Seitz, M., Horvath, K., Berghold, A., & Siebenhofer, A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009122.pub2 · Cited by 299
Hernández, C., Bogdanov, P., Corraliza, L., García-Ramírez, M., Solà-Adell, C., Arranz, J. A., Arroba, A. I., Valverde, A. M., & Simó, R. (2016) · Diabetes · doi:10.2337/db15-0443 · Cited by 267
Lauritzen, T., Frost-Larsen, K., Larsen, H.-W., Deckert, T., & The Steno Study Group (1985) · Diabetes · doi:10.2337/diab.34.3.s74 · Cited by 252
Aiello, L. P., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2251 · Cited by 216
Poulaki, V., Qin, W., Joussen, A. M., Hurlbut, P., Wiegand, S. J., Rudge, J., Yancopoulos, G. D., & Adamis, A. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213776 · Cited by 190
on behalf of the AdRem* project team and ADVANCE management committee, Beulens, J. W. J., Patel, A., Vingerling, J. R., Cruickshank, J. K., Hughes, A. D., Stanton, A., Lu, J., McG Thom, S. A., Grobbee, D. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1457-x · Cited by 188
The Action to Control Cardiovascular Risk in Diabetes Follow-On (ACCORDION) Eye Study Group and the Action to Control Cardiovascular Risk in Diabetes Follow-On (ACCORDION) Study Group (2016) · Diabetes Care · doi:10.2337/dc16-0024 · Cited by 178
Feldman-Billard, S., Larger, É., & Massin, P. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.10.014 · Cited by 162
WORSENING OF DIABETIC RETINOPATHY WITH STRICT CONTROL OF BLOOD SUGAR
Hooymans, J. M. M., Ballegooie, E. V., Schweitzer, N. M. J., Doorenbos, H., Reitsma, W. D., & Sluiter, W. J. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90464-0 · Cited by 139
Diabetic retinopathy: clinical findings and management.
Viswanath, K., & McGavin, D. D. M. (2003) · PubMed · Cited by 133
Coleman, K. J., Haneuse, S., Johnson, E., Bogart, A., Fisher, D. P., O’Connor, P. J., Sherwood, N. E., Sidney, S., Theis, M. K., Anau, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0194 · Cited by 122
Refractive changes in diabetic patients during intensive glycaemic control
Okamoto, F. (2000) · British Journal of Ophthalmology · doi:10.1136/bjo.84.10.1097 · Cited by 113
Bergenstal, R. M., Morse, P. H., Rubenstein, A. H., Jj, B., Bilous, R., Keen, H., Pickup, J. C., Viberti, G. C., Gosh, G., KOHNER, E. M., et al. (1988) · JAMA · Cited by 110
Abcouwer, S. F., Lin, C.-M., Wolpert, E. B., Shanmugam, S., Schaefer, É., Freeman, W. M., Barber, A. J., & Antonetti, D. A. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5264 · Cited by 96
Hernández, C., Bogdanov, P. M., Solà-Adell, C., Sampedro, J., Valeri, M., Genís, X., Simó‐Servat, O., García‐Ramírez, M., & Simó, R. (2017) · Diabetologia · doi:10.1007/s00125-017-4388-y · Cited by 95
Jingi, A. M., Tankeu, A. T., Ateba, N. A., & Noubiap, J. J. (2017) · BMC Endocrine Disorders · doi:10.1186/s12902-017-0213-3 · Cited by 95
Rosenstock, J., Fonseca, V. A., McGill, J. B., Riddle, M. C., Hallé, J., HRAMIAK, I. M., Johnston, P., & Davis, J. L. (2009) · Diabetologia · doi:10.1007/s00125-009-1415-7 · Cited by 88
GLP-1R as a Target for the Treatment of Diabetic Retinopathy: Friend or Foe?
Simó, R., & Hernández, C. (2017) · Diabetes · doi:10.2337/db16-1364 · Cited by 86
Dicembrini, I., Nreu, B., Scatena, A., Andreozzi, F., Sesti, G., Mannucci, E., & Monami, M. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-1031-9 · Cited by 85
Effects of Intensified Insulin Treatment on Various Lesions of Diabetic Retinopathy
Oslo Study Group, Brinchmann-Hansen, O., Dahl‐Jørgensen, K., Hanssen, K. F., & Sandvik, L. (1985) · American Journal of Ophthalmology · doi:10.1016/0002-9394(85)90618-x · Cited by 84
Intravitreal Injection of Exendin-4 Analogue Protects Retinal Cells in Early Diabetic Rats
Zhang, Y., Zhang, J., Wang, Q., Lei, X., Chu, Q., Xu, G.-T., & Ye, W. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4727 · Cited by 84
The DPP4 Inhibitor Linagliptin Protects from Experimental Diabetic Retinopathy
Dietrich, N., Kolibabka, M., Busch, S., Bugert, P., Kaiser, U., Lin, J., Fleming, T. H., Morcos, M., Klein, T., Schlotterer, A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167853 · Cited by 84
Proliferative effects of insulin analogues on mammary epithelial cells
Mayer, D., Shukla, A. K., & Enzmann, H. G. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450801900645 · Cited by 78
Mishra, M., & Kowluru, R. A. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19759 · Cited by 70
Fan, Y., Liu, K., Wang, Q., Ruan, Y., Ye, W., & Zhang, Y. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.05.004 · Cited by 67
Shurter, A., Genter, P. M., Ouyang, D., & Ipp, E. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.03.018 · Cited by 61
Progression of diabetic retinopathy after bariatric surgery
Murphy, R., Jiang, Y., Booth, M., Babor, R., MacCormick, A. D., Hammodat, H., Beban, G. R., Barnes, R. M., & Vincent, A. L. (2015) · Diabetic Medicine · doi:10.1111/dme.12727 · Cited by 61
The Impact of Bariatric Surgery on Diabetic Retinopathy: A Systematic Review and Meta-Analysis
Cheung, D. C., Switzer, N. J., Ehmann, D. S., Rudnisky, C. J., Shi, X., & Karmali, S. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1539-9 · Cited by 53
Thomas, R., Prior, S. L., Barry, J. D., Luzio, S. D., Eyre, N., Caplin, S., Stephens, J. W., & Owens, D. R. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.10.006 · Cited by 50
Near-normoglycemia and late diabetic complications. The Oslo Study.
Dahl‐Jørgensen, K. (1987) · PubMed · Cited by 50
The impact of improved glycaemic control with GLP-1 receptor agonist therapy on diabetic retinopathy
Varadhan, L., Humphreys, T., Walker, A. B., & Varughese, G. I. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.12.041 · Cited by 49
GLP-1 agonist treatment: Implications for diabetic retinopathy screening
Varadhan, L., Humphreys, T., Hariman, C., Walker, A. B., & Varughese, G. I. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.08.017 · Cited by 47
Fadini, G. P., Sarangdhar, M., & Avogaro, A. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000475 · Cited by 44
Merlotti, C., Ceriani, V., Morabito, A., & Pontiroli, A. E. (2017) · Obesity Reviews · doi:10.1111/obr.12490 · Cited by 43
The Effect of Bariatric Surgery on Diabetic Retinopathy: Good, Bad, or Both?
Gorman, D. M., le Roux, C. W., & Docherty, N. G. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.5.354 · Cited by 41
Effect of rapid glycemic control on progression of diabetic retinopathy.
Funatsu, H., Yamashita, H., Ohashi, Y., & Ishigaki, T. (1992) · PubMed · Cited by 40
The Influence of Glucose Concentration and Hypoxia on VEGF Secretion by Cultured Retinal Cells
Kennedy, A., & Frank, R. N. (2011) · Current Eye Research · doi:10.3109/02713683.2010.521968 · Cited by 38
Kim, Y. J., Shin, S. H., Han, D. J., Kim, Y. H., Lee, J. Y., Yoon, Y. H., & Kim, J.-G. (2017) · Transplantation · doi:10.1097/tp.0000000000001958 · Cited by 36
Diabetic retinopathy and the effect of pregnancy.
Mallika, P., Tan, A. S. A., Aziz, S., Asok, T., Alwi, S. S., & Intan, G. (2010) · Europe PMC (PubMed Central) · Cited by 35
Does bariatric surgery prevent progression of diabetic retinopathy?
Chen, Y., Laybourne, J. P., Sandinha, T., de Alwis, N. M. W., Avery, P. J., & STEEL, D. H. (2017) · Eye · doi:10.1038/eye.2017.119 · Cited by 31
Hypoglycaemia exacerbates ischaemic retinal injury in rats
Casson, R. J. (2004) · British Journal of Ophthalmology · doi:10.1136/bjo.2003.024661 · Cited by 30
The effect of pregnancy on the progression of diabetic retinopathy
Toda, J., Kato, S., Sanaka, M., & Kitano, S. (2016) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-016-0464-y · Cited by 30
Wu, H., Jiang, C., Gan, D., Liao, Y., Ren, H., Sun, Z., Zhang, M., & Xu, G. (2011) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-011-1677-x · Cited by 23
Azad, N., Bahn, G., Emanuele, N., Agrawal, L., Ge, L., Reda, D. J., Klein, R., Reaven, P. D., Hayward, R. A., & the VADT Study Group (2016) · Diabetes Care · doi:10.2337/dc15-1897 · Cited by 19
Gastric bypass surgery does not increase the risk for sight‐threatening diabetic retinopathy
Morén, Å., Sundbom, M., Ottosson, J., & Granstam, E. (2017) · Acta Ophthalmologica · doi:10.1111/aos.13555 · Cited by 17
Hernández, C., Zapata, M. Á., Losada, E., Villarroel, M., García‐Ramírez, M., García‐Arumí, J., & Simó, R. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1093 · Cited by 15
Cited by
Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy
Yang, J., & Liu, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.816400 · Cited by 281
Bethel, M. A., Diaz, R., Castellana, N., Bhattacharya, I., Gerstein, H. C., & Lakshmanan, M. C. (2021) · Diabetes Care · doi:10.2337/dc20-1815 · Cited by 151
Lakhani, M., Kwan, A. T. H., Mihalache, A., Popovic, M. M., Nanji, K., Xie, J. S., Feo, A., Rabinovitch, D., Shor, R., Sadda, S., et al. (2025) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2025.05.007 · Cited by 70
Bays, H. E., Fitch, A., Christensen, S., Burridge, K., & Tondt, J. (2022) · Obesity Pillars · doi:10.1016/j.obpill.2022.100018 · Cited by 68
Yoshida, Y., Joshi, P., Barri, S., Wang, J., Corder, A. L., O'Connell, S. S., & Fonseca, V. A. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108255 · Cited by 65
Metadata
- Authors
- Bain, S. C., Klufas, M. A., Ho, A., & Matthews, D. R.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2018-10-15
- Volume
- 21
- Issue
- 3
- Pages
- 454-466
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2891332575
- Cited by
- 299
- References
- 73
- FWCI
- 13.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.